RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Immunomodulatory Effects of Anesthetic Techniques in Lung Cancer Surgery: A Systematic Review and Meta-Analysis.
Immunomodulatory Effects of Anesthetic Techniques in Lung Cancer Surgery: A Systematic Review and Meta-Analysis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肺癌是全球癌症相关死亡的主要原因之一。尽管出现了众多新型治疗药物,但在许多情况下,手术切除仍是主要治疗手段。越来越多的证据表明,所选择的麻醉技术会导致围手术期免疫抑制,从而影响癌症复发和预后。本系统综述旨在全面总结当前关于肺癌手术中使用的各种麻醉技术所诱导的免疫反应调节的文献,特别侧重于细胞免疫。
系统检索了 PubMed、Scopus 和 Cochrane 数据库,检索时间从 2023 年 11 月至 2024 年 3 月,以确定符合纳入标准的随机对照试验(RCT)。
共纳入 7 项 RCT。其中 4 项 RCT 比较了单纯全身麻醉与全身麻醉联合硬膜外麻醉。随后的 meta 分析显示,全身麻醉联合硬膜外麻醉对 CD3+ 细胞计数(术后 24 h SMD -0.42,95% CI -0.70 至 -0.13;术后 72 h SMD -0.86,95% CI -1.48 至 -0.23)、CD4+ 细胞计数(手术结束时 SMD -0.41,95% CI -0.69 至 -0.12;72 h 后 SMD -0.56,95% CI -0.85 至 -0.27)以及 CD4+/CD8+ 比值(手术后即刻 SMD -0.31,95% CI -0.59 至 -0.02;术后 24 h SMD -0.50,95% CI -0.86 至 -0.14;72 h 后 SMD -0.60,95% CI -0.89 至 -0.31)产生了积极影响。关于 CD8+ 和 NK 细胞计数的汇总结果尚无定论。其余三项研究比较了基于挥发性麻醉药的麻醉与全静脉麻醉(TIVA)。由于这些研究之间存在差异,定性分析未能得出结论,而定量分析不可行。
在全身麻醉中辅以硬膜外麻醉对CD3+和CD4+细胞计数以及CD4+/CD8+比值有有利影响。目前的结果以及麻醉技术对其他免疫细胞的影响,必须通过进一步的高质量研究加以巩固。
Background and Objectives : Lung cancer represents one of the principal causes of cancer-associated mortality worldwide. Despite the numerous novel therapeutic agents, surgical resection remains, in many cases, the mainstay treatment. A growing body of evidence indicates that the anesthetic technique of choice contributes to perioperative immunosuppression, thus having an impact on cancer recurrence and prognosis. The aim of this systematic review is to provide a thorough summary of the current literature regarding the modulation of the immune response induced by the various anesthetic techniques that are used in lung cancer surgery, with a particular emphasis on cellular immunity. Materials and Methods : PubMed, Scopus, and the Cochrane databases were systematically searched from November 2023 up to March 2024 to identify randomized controlled trials (RCTs) that met the eligibility criteria. Results : A total of seven RCTs were included. Four of the RCTs compared the administration of general anesthesia alone versus general anesthesia combined with epidural anesthesia.
The subsequent meta-analysis showed that the combination of general and epidural anesthesia exerted a positive impact on the cell counts of the CD3+ cells (SMD -0. 42, 95% Cl -0. 70 to -0. 13 24 h postoperatively and SMD -0. 86 95% Cl -1. 48 to -0. 23 72 h postoperatively), the CD4+ cells (SMD -0. 41 95% Cl -0. 69 to -0. 12 at the end of surgery and SMD -0. 56 95% Cl -0. 85 to -0. 27 72 h later), and the CD4+/CD8+ ratio (SMD -0. 31 95% Cl -0. 59 to -0. 02 immediately after surgery, SMD -0. 50 95% Cl -0. 86 to -0. 14 24 h postoperatively, and SMD -0. 60 95% Cl -0. 89 to -0. 31 72 h later).
The pooled results regarding CD8+ and NK cell counts were inconclusive. The remaining three studies compared volatile-based anesthesia with total intravenous anesthesia (TIVA). Due to disparities between these studies, qualitative analysis was inconclusive, whereas quantitative analysis was not feasible.
Conclusions : The supplementation of general anesthesia with epidural anesthesia favorably impacts CD3+ and CD4+ cell counts, as well as the CD4+/CD8+ ratio. The present results and the effects of anesthetic technique on other immune cells must be consolidated with further high-quality studies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。